Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 339 results for "lupin"

Lupin arm gets USFDA nod to market generic Zyvox tablets
Money Control

Lupin gets tentative USFDA nod for generic anti-depressant

Company's shares were trading at Rs 1,524.70, up 0.14% in the afternoon trade on BSE Business Standard, 3 days ago

521 images for lupin

Money Control, 3 days ago
Business Standard India, 3 days ago, 1 week ago
GQ, 5 days ago
Business Standard India, 5 days ago, 3 days ago, 3 days ago
Financial Express, 1 week ago
First, 3 days ago
Anime News Network, 4 days ago
Money Control

Lupin looks to launch 25 products in US this fiscal

"We expect to launch a good number of products between India and Gavis (US). We are hoping to launch 25 plus products, FDA permitting. So, a good number of launches that we expect for the year," Lupin CEO Vinita Gupta said in a conference call.
 Money Control1 week ago Lupin to launch 25 products in US this fiscal  Hindu Business Line2 weeks ago ‚Äč Lupin looks to launch 25 products in US this fiscal  Economic Times2 weeks ago
India Infoline

Aurobindo a bright spot in Indian pharma

Even as larger peers Sun Pharmaceutical and Lupin faltered on the bourses despite strong June quarter (Q1) earnings, Aurobindo Pharma gained seven per cent on Wednesday. The company had declared its quarterly results after market hours on Tuesday. ...
 Business Standard5 days ago Buzzing stocks: Aurobindo Pharma rises, Lupin slips, Majesco up  India Infoline5 days ago Lupin launches contraceptive drug  Business Line1 month ago USFDA boost for pharma shares; Strides, Alembic up over 7% in a week  Business Standard1 month ago

Support for Nifty at 8600-8550; HDFC bullish play: Prakash Gaba

According to Prakash Gaba of, HDFC and Jain Irrigation are bullish plays while Axis Bank and Lupin are bearish plays.
 Money Control6 days ago
Money Control

Lupin named most reputed pharma brand in India

Lupin has been named as the most reputed pharmaceutical brand in India followed by Sun Pharma, Cipla and Dr.Reddys in that order in Indias Most Reputed Brands list. Among the global brands, GSK leads the way followed by Pfizer and Abbott. As many as 58 pharma ...
 The Hindu1 week ago Lupin tops most reputed pharma brand list  Money Control1 week ago

Lupin to file its first biosimilar etanercept for approval in Japan in 2017

MD Nilesh Gupta says Lupin is developing a pipeline of four biosimilars focussed on regulated markets Hyderabad: Lupin Ltd., India's third largest drug maker plans to file its first biosimilar, etanercept, for approval in Japan, the world's second ...
 Livemint.com2 weeks ago Lupin hits over 1-month low; results fail to cheer market  Sify2 weeks ago Lupin Q1 net soars 55% to Rs 882cr  Times of India2 weeks ago Lupin posts better-than-expected profit as new drugs boost U.S. sales  Nikkei Asian Review2 weeks ago
Financial Express

Lupin extends downtrend; shares slide nearly 4%

Extending its previous day's slide, shares of drug major Lupin today fell by nearly 4 per cent after the company's June quarter earnings failed to impress investors. The scrip went down by 3.89 per cent to settle at Rs 1,545.05 on BSE. During the ...
 Business Standard2 weeks ago Lupin shares plunge over 3% on uncertainty over US market  Economic Times2 weeks ago Lupin Faces Heat In US Market, Shares Slump 8% In Two Days  NDTV Profit2 weeks ago Lupin, Jubilant Life Sciences among 7 stocks that hogged limelight in Tuesday's trade  Financial Express2 weeks ago

Lupin ends 1% lower; receives two Form 483 for Dabhasa unit

The pharma major informed the stock exchanges today that the US FDA inspected its Dabhasa facility from 29th June to 6th July 2016.
 India Infoline1 month ago Lupin: Updates on USFDA inspection at Dabhasa facility  Money Control1 month ago USFDA clears Lupin's Goa plant, closes July 2015 inspection  Business Standard1 month ago Lupin receives EIR from US FDA for Goa facility  Business Standard1 month ago

Competition Commission penalizes KCDA and Lupin for indulging in unethical trade practices

The Competition Commission of India (CCI) has penalized the Karnataka Chemists & Druggists Association (KCDA), Lupin Diabetes Care Unit and Lupin for indulging in practices which are against the Competition Act 2002. In its order via Case No. 71 ...
 PharmaBiz3 weeks ago Competition Commission penalizes state drug association and Lupin  Times of India3 weeks ago Competition Commission of India Imposes Penalty on Karnataka Chemists & Druggist Association and pharmaceutical company Lupin  Press Information Bureau4 weeks ago CCI imposes penalty on Karnataka Chemists & Druggist Association and Lupin  India Infoline3 weeks ago

Lupin falls by 3.89 pc to Rs 1545.05

Mumbai, Aug 10 (UNI) Lupin was tumbld down today by 3.89 pc to Rs 1545.05 to be the top losers in the 30 share sensex pack at the Bombay Stock Exchange (BSE). The other losers were Reliance Industries by 2.63 pc to Rs 1002.80, HeroMoto Corp by 2.56 ...
 United News of India2 weeks ago Lupin falls by 5.03 pc to Rs 1607.60  United News of India2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - lupin
Get updated on latest news & your favorite topics right in your inbox!
More     Less